Gottlieb, AB, A Blauvelt, D Tha?i, Y Poulin, F Brock, C Arendt, M Boehnlein, and K Reich. “Reductions in Absolute PASI Over 144 Weeks of Treatment With Certolizumab Pegol in Patients With Plaque Psoriasis: Pooled Analysis from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s84. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/1117.